Voyager names new business chief amid ‘significant interest’ from partners; Oncopeptides faces another CEO, CFO reset

Beth Shafer was taught to leave a place better than she found it. As Voyager Therapeutics’ new chief business officer, that’s exactly what she intends to do.

Voyager announced Monday that it tapped the Takeda veteran to its C-suite. Shafer will lead the business strategy as…
Click here to view original post